Celltrion Healthcare Co.,Ltd.
Silchai Kositpantawong is a Specialty Sales Representative at Takeda, responsible for marketing Entyvio and Mezavant XL in key hospitals in Thailand. Previously, Silchai served as an Account Professional at Celltrion Healthcare, focusing on a range of pharmaceutical products within Ramathibodi Hospital. Silchai's experience includes roles as a Medical Science Liaison at Pfizer, where scientific expertise was provided on oncology and vaccines, as well as a Medical Sales Representative at Viatris, specializing in oncology information dissemination. Additionally, Silchai gained clinical experience as a Clinical Pharmacist at Ramathibodi Hospital, participating in heart failure and pharmaceutical intravenous administration teams. Silchai holds a Doctor of Pharmacy degree from Prince of Songkla University.
This person is not in any offices
Celltrion Healthcare Co.,Ltd.
Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7